Health Catalyst, Inc. — Director's Dealing 2019

Jul 25, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2019-07-24

Reporting Person: Pramoda Anita (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series E Preferred Stock	$		Common Stock (94348.0)		Indirect
Stock Option (Right to Buy)	$10.4	2026-04-28	Common Stock (62500.0)		Direct
Stock Option (Right to Buy)	$10.66	2027-04-27	Common Stock (20000.0)		Direct

Footnotes

F1: Each share of Series E Preferred Stock is convertible on a one-for-one basis into the number of shares of the Issuer's common stock shown in column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series E Preferred Stock has no expiration date.

F2: The shares are held by Omkara, LLC and the Reporting Person wholly-owns and holds the voting and dispositive power of these shares.

F3: 25% of the shares vested on April 28, 2017, and the remaining 75% vest in 36 equal monthly installments thereafter.

F4: 25% of the shares vested on April 27, 2018, and the remaining 75% vest in 36 equal monthly installments thereafter.